Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

12.5%

3 terminated out of 24 trials

Success Rate

81.3%

-5.3% vs benchmark

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed with results

Key Signals

3 with results81% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (9)
P 1 (2)
P 2 (8)
P 3 (3)
P 4 (1)

Trial Status

Completed13
Unknown5
Terminated3
Recruiting1
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

81.3%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07347743Not ApplicableRecruitingPrimary

Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.

NCT04537494Not ApplicableCompletedPrimary

PRobiotics for EVEry Newborn Trial

NCT06967870Not ApplicableNot Yet Recruiting

The Effect of Cranial Osteopathy Intervention in Preterm Babies

NCT05554991Not ApplicableTerminatedPrimary

Human Milk Oligosaccharide (HMO) Supplementation in Colic Management

NCT02865564Not ApplicableCompleted

Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics

NCT05052476Not ApplicableCompletedPrimary

First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic

NCT05198700Phase 2WithdrawnPrimary

The Effect of Probiotics on Symptoms of Infantile Colic

NCT01532518Phase 2CompletedPrimary

Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

NCT05685030Phase 2UnknownPrimary

Probiotics Strains for Infant Colic

NCT04983069UnknownPrimary

Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity

NCT02586558Not ApplicableTerminatedPrimary

Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants

NCT01849991Phase 1Completed

Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic

NCT00922727Phase 1CompletedPrimary

Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults

NCT02242292Phase 2CompletedPrimary

Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort

NCT01715220Phase 2UnknownPrimary

Treatment of Suspected Cholelithiasis With Nitroglycerin

NCT01279265Not ApplicableCompletedPrimary

Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic

NCT02577133Phase 2UnknownPrimary

Prevention of Colic With the Probiotic Lactobacillus Reuteri

NCT01997593Phase 2Completed

Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected

NCT01541046Phase 2CompletedPrimary

Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic

NCT00177086Phase 3Completed

Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi

Scroll to load more

Research Network

Activity Timeline